Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 7/9/09  and contains information from public web pages.

Mr. Rudolf Maag

Wrong Rudolf Maag?
 
Background

Employment History

Board Memberships and Affiliations

Education

  • commercial diploma
  • degree
29 Total References
Web References
Straumann - International > Investor relations > Corporate governance > Board of Directors
www.straumann.com, 9 July 2009 [cached]
Members: Dr h.c. Rudolf Maag (Chair), Dr Sebastian Burckhardt, Jürg Morant.
Geberit AG Annual Report 2005
www2.geberit.com, 1 Jan 2005 [cached]
Rudolf Maag (1946)
...
The term of office for both Dr Robert Heberlein and Rudolf Maag is set to expire at the general meeting on 28 April 2006.
...
Rudolf Maag will be stepping down from the Board of Directors.
...
Kurt E. Feller (Chairman), Dr Robert Heberlein, Günter F. Kelm, Rudolf Maag, Klaus Weisshaar
...
Kurt E. Feller (Chairman), Günter F. Kelm, Rudolf Maag
...
Rudolf Maag
Rudolf Maag - Chairman of ...
dentistry.all-details.com, 22 July 2009 [cached]
Rudolf Maag - Chairman of the Board, Chair Finance and Audit Committee.
Geberit AG Annual Report 2005
www2.geberit.com, 1 Jan 2005 [cached]
Rudolf Maag (1946)
...
Rudolf Maag holds a commercial diploma and graduated with the degree of an INSEAD MBA.He started his career in 1968 with UTC (Basler Handelsgesellschaft).In 1973, he joined Sandoz AG where he held various management positions in the agricultural division, among other functions, as Marketing and Sales Director USA and Head of Division Brazil.In 1986, Rudolf Maag joined Institut Straumann AG as a Director.Four years later, he founded Stratec Medical by way of a management buy-out.Following a successful Initial Public Offering in 1996, Stratec merged with the US company Synthes Ltd. to form Synthes-Stratec.Rudolf Maag became Vice Chairman of the Board of Directors and CEO.In 2000, he left Synthes-Stratec to act as an independent member of various Boards of Directors as well as a private equity investor.
...
The term of office for both Dr Robert Heberlein and Rudolf Maag is set to expire at the general meeting on 28 April 2006.
...
Rudolf Maag will be stepping down from the Board of Directors.
...
The members of the Personnel Committee are Kurt E. Feller (Chairman), Günter F. Kelm and Rudolf Maag.
...
The Audit Committee is composed of Kurt E. Feller (Chairman), Dr Robert Heberlein, Günter F. Kelm, Rudolf Maag and Klaus Weisshaar.
Mr Hansjörg Wyss, currently Chairman and ...
www.stratec.com, 26 Sept 2002 [cached]
Mr Hansjörg Wyss, currently Chairman and Chief Executive Officer of SYNTHES, will assume the position of Chairman of SYNTHES-STRATEC, and Mr Rudolf Maag, currently Chief Executive Officer of STRATEC, will serve as President and Chief Executive Officer of the combined entity.
...
In addition to Mr Rudolf Maag, the principal Executive Officers for SYNTHES-STRATEC will include Charles Hedgepeth (Vice President – USA).
...
Mr Rudolf Maag, who currently controls 69% of the voting rights and 51% of the share capital of STRATEC, has accepted the combination terms and supports the exchange offer.
The combination and the offering of SYNTHES-STRATEC shares are subject to approval by various competition authorities in both the US and Europe, to an 80% acceptance by votes and by capital of the exchange offer of all STRATEC shareholders and to other customary conditions to be published in the exchange offer documentation.It is anticipated that the combination will be completed by May 1999.Furthermore, market conditions permitting, it is currently contemplated that a secondary share offering representing approximately 10% of the shares of SYNTHES-STRATEC will be conducted within 12 months of the closing of the combination, increasing the free float of SYNTHES-STRATEC to approximately 25% of the shares outstanding.
STRATEC has retained the services of Merrill Lynch & Co. to render a fairness opinion in connection with the combination.On February 23, 1999, Merrill Lynch & Co. rendered its opinion to the Board of Directors of STRATEC that subject to the assumptions and limitations set forth therein and as of the date thereof, the exchange ratio was fair, from a financial point of view, to the shareholders of STRATEC.
Other People with the name "Maag":
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304